Dihuang Baoyuan Granules
AssetAlso prescription B
Traditional Chinese herbal formulation regulating blood glucose and metabolic homeostasis
- Stage
- Phase 2
- Modality
- Other
- Target
- Insulin/IGF-1 signalling
- 3
- Indications
- 1
- Trial
- 1
- Developer
Indications
3Diabetes
Phase 2, Completed, NCT06575478, clinicaltrials.gov, 7 Oct 2026
Type 2 diabetes
Phase 2, Completed, NCT06575478, clinicaltrials.gov, 7 Oct 2026
Type2diabetes
Phase 2, Completed, NCT06575478, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.